153 CLINICAL CONSEQUENCES OF OFF-LABEL REDUCED DOSING OF NOACS IN AF ((anticoagul*:ti,ab OR ‘anti-coagul*’:ti,ab OR ‘anticoagulant agent’/exp) AND (novel:ti,ab OR new:ti,ab OR direct:ti,ab) OR (non*:ti,ab AND ((vitamin*:ti,ab AND antagonist*:ti,ab) OR (VKA*:ti,ab))))) AND ‘article’/it AND [embase]/lim AND [1-1-2009]/sd NOT [10-07-2022]/sd 8
RkJQdWJsaXNoZXIy MTk4NDMw